Risks and benefits of HIFU therapy in patients with malignant solid tumors: a real-world, bivariate cohort-based study

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400087745

Enrollment

Unknown

Registered

2024-08-02

Start date

2023-04-12

Completion date

Unknown

Last updated

2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignancy

Interventions

Malignant tumor patient management queue:NA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age =18 years old; 2. Patients with pathologically or clinically confirmed diagnosis of intermediate or advanced malignant tumors. Patients who fulfill the above two criteria are eligible for inclusion in the study.

Exclusion criteria

Exclusion criteria: 1. early pathological stage of tumors; 2. cognitive impairment; 3. patients with missing medical records that could not be replaced. Patients who met any of the above criteria were excluded.

Design outcomes

Primary

Measure	Time frame
Tumor Markers;Imaging indicators;	—

Secondary

Measure	Time frame
blood routine;Liver function;Renal function;Biochemical Indicators;Coagulation;	—

Countries

China

Contacts

Public ContactZhou Kun

The Second Affiliated Hospital of Chongqing Medical University

zhoukun@hospital.cqmu.edu.cn+86 159 2309 8669

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026